Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC
This study has been completed.
Sponsor:
Sunesis Pharmaceuticals
Information provided by:
Sunesis Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00252382
First received: November 9, 2005
Last updated: May 9, 2007
Last verified: January 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | April 2007 |
| Estimated Primary Completion Date: | No date given |